Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
Junwei Yang, … , Kari Nejak, Youhua Liu
Junwei Yang, … , Kari Nejak, Youhua Liu
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1525-1538. https://doi.org/10.1172/JCI16219.
View: Text | PDF
Article Nephrology

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

  • Text
  • PDF
Abstract

Research Article

Authors

Junwei Yang, Ryan W. Shultz, Wendy M. Mars, Rodney E. Wegner, Yingjian Li, Chunsun Dai, Kari Nejak, Youhua Liu

×

Figure 8

Options: View larger image (or click on image) Download as PowerPoint
Deficiency of tPA preserves the functional integrity of TBM in the obstr...
Deficiency of tPA preserves the functional integrity of TBM in the obstructed kidneys. TBM functional integrity was determined by bacterial translocation across the reconstituted TBM. (a) Schematic depiction of experimental procedures. Matrigels (15 μm thick) analogous to native TBM matrix were formed on Transwell filters and incubated with whole-tissue lysates of the obstructed kidneys collected 7 days after UUO from tPA+/+ and tPA–/– mice. The integrity of the Matrigels was assessed by bacterial translocation through the gels. Representative plates show the colonies formed from the bacteria that passed through the Matrigels after incubation with tissue extracts from either tPA+/+ (b) or tPA–/– (c) mice. (d) Graphic presentation of the numbers of bacteria translocated through the Matrigels (n = 5). *P < 0.01 vs. tPA+/+ mice. (e) Zymographic analysis shows the specificity of MMP-9 inhibitor. Tissue lysates from the obstructed kidneys of either tPA+/+ or tPA–/– mice were separated on a polyacrylamide gel containing 1 mg/ml gelatin. A potent MMP-9 inhibitor (MMP inhibitor II) was included in the developing buffer at a concentration of 10 nM. The locations of bands corresponding to MMP-9 and MMP-2 are indicated. Numbered lanes indicate two animals per group. (f) Graphic presentation of the numbers of bacteria translocated through Matrigels preincubated with kidney lysates in the presence of 10 nM MMP-9 inhibitor. No statistically significant difference was found between tPA+/+ and tPA–/– groups.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts